RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 151 filers reported holding RA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 16.18 and the average weighting 0.6%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,851,808 | $20,453,000 | 1.57% |
NEA Management Company, LLC | 5,493,636 | $29,171,000 | 1.30% |
Foresite Capital Management IV, LLC | 450,000 | $2,390,000 | 0.99% |
Novo Holdings A/S | 1,465,838 | $7,784,000 | 0.98% |
Consonance Capital Management LP | 1,454,761 | $7,725,000 | 0.71% |
VHCP Management II, LLC | 544,612 | $2,892,000 | 0.70% |
ACUTA CAPITAL PARTNERS, LLC | 270,000 | $1,434,000 | 0.23% |
Athanor Capital, LP | 67,150 | $357,000 | 0.16% |
Rock Springs Capital Management LP | 600,000 | $3,186,000 | 0.14% |
Eventide Asset Management | 388,000 | $2,060,000 | 0.10% |